MedPath

Social Effects of Alcohol

Early Phase 1
Completed
Conditions
Alcohol Drinking
Interventions
Drug: Placebo
Registration Number
NCT05826951
Lead Sponsor
University of Chicago
Brief Summary

In this study the investigator will assess the effect of a moderate dose of alcohol on emotional responses and feelings of connection during a dyadic semi-structured social interaction

Detailed Description

The study will use a within-subject crossover design with four sessions, in which participants receive alcohol or placebo across sessions. During the four sessions, the participants will engage in a conversation with a stranger, and emotional responses and feelings of connection will be assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • non-problem alcohol consumption of 2-20 drinks per week
  • high school diploma or equivalent
  • BMI between 19 and 26
  • verbal fluency in English
Exclusion Criteria
  • High blood pressure
  • Any medical condition requiring regular medication
  • Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis
  • Women who are pregnant or trying to become pregnant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Alcohol-alcoholAlcoholBoth conversation partners receive alcohol
alcohol-placeboAlcoholparticipant receives alcohol and conversation partner receives placebo
placebo-alcoholPlaceboparticipant receives placebo and conversation partner receives alcohol
placebo-placeboPlaceboBoth conversation partners receive placebo
Primary Outcome Measures
NameTimeMethod
self-reported feelings of connectionat the end of each session (3.5 hrs post-drug administration). Changes across sessions will be assessed

self-other overlap measure ratings 1-7, greater ratings indicates greater feelings of connection

facial emotional responsesduring the length of the conversation (45 min)

alterations in the rate of positive facial expressions during the conversation, measured by muscle action units. These will be compared between the drug and placebo sessions

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath